These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38307685)

  • 1. Overdose mortality incidence and supervised consumption services in Toronto, Canada: an ecological study and spatial analysis.
    Rammohan I; Gaines T; Scheim A; Bayoumi A; Werb D
    Lancet Public Health; 2024 Feb; 9(2):e79-e87. PubMed ID: 38307685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation contexts and the impact of policing on access to supervised consumption services in Toronto, Canada: a qualitative comparative analysis.
    Bardwell G; Strike C; Altenberg J; Barnaby L; Kerr T
    Harm Reduct J; 2019 May; 16(1):30. PubMed ID: 31046759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supervised consumption service use and recent non-fatal overdose among people who inject drugs in Toronto, Canada.
    Scheim AI; Bouck Z; Tookey P; Hopkins S; Sniderman R; McLean E; Garber G; Baral S; Rourke SB; Werb D
    Int J Drug Policy; 2021 Jan; 87():102993. PubMed ID: 33160158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid-related overdose deaths among people experiencing homelessness, 2017 to 2021: A population-based analysis using coroner and health administrative data from Ontario, Canada.
    Booth RG; Shariff SZ; Carter B; Hwang SW; Orkin AM; Forchuk C; Gomes T
    Addiction; 2024 Feb; 119(2):334-344. PubMed ID: 37845790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opening Canada's first Health Canada-approved supervised consumption sites.
    Patterson T; Bharmal A; Padhi S; Buchner C; Gibson E; Lee V
    Can J Public Health; 2018 Aug; 109(4):581-584. PubMed ID: 30039262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'It's our safe sanctuary': Experiences of using an unsanctioned overdose prevention site in Toronto, Ontario.
    Foreman-Mackey A; Bayoumi AM; Miskovic M; Kolla G; Strike C
    Int J Drug Policy; 2019 Nov; 73():135-140. PubMed ID: 31654936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City.
    Behrends CN; Paone D; Nolan ML; Tuazon E; Murphy SM; Kapadia SN; Jeng PJ; Bayoumi AM; Kunins HV; Schackman BR
    J Subst Abuse Treat; 2019 Nov; 106():79-88. PubMed ID: 31540615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating networked drug checking services in Toronto, Ontario: study protocol and rationale.
    Maghsoudi N; McDonald K; Stefan C; Beriault DR; Mason K; Barnaby L; Altenberg J; MacDonald RD; Caldwell J; Nisenbaum R; Leece P; Watson TM; Tupper KW; Kufner L; Scheim AI; Werb D;
    Harm Reduct J; 2020 Jan; 17(1):9. PubMed ID: 32204713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The estimated costs and benefits of a hypothetical supervised consumption site in Providence, Rhode Island.
    Chambers LC; Hallowell BD; Zang X; Rind DM; Guzauskas GF; Hansen RN; Fuchs N; Scagos RP; Marshall BDL
    Int J Drug Policy; 2022 Oct; 108():103820. PubMed ID: 35973341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic.
    Irvine MA; Kuo M; Buxton JA; Balshaw R; Otterstatter M; Macdougall L; Milloy MJ; Bharmal A; Henry B; Tyndall M; Coombs D; Gilbert M
    Addiction; 2019 Sep; 114(9):1602-1613. PubMed ID: 31166621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of the COVID-19 pandemic on access to supervised consumption programs.
    Gubskaya E; Kennedy MC; Hayashi K; Cui Z; Milloy MJ; Kerr T
    Subst Abuse Treat Prev Policy; 2023 Mar; 18(1):16. PubMed ID: 36899417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Willingness to Use Safe Consumption Spaces among Opioid Users at High Risk of Fentanyl Overdose in Baltimore, Providence, and Boston.
    Park JN; Sherman SG; Rouhani S; Morales KB; McKenzie M; Allen ST; Marshall BDL; Green TC
    J Urban Health; 2019 Jun; 96(3):353-366. PubMed ID: 31168735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mobile supervised consumption services in Rural British Columbia: lessons learned.
    Mema SC; Frosst G; Bridgeman J; Drake H; Dolman C; Lappalainen L; Corneil T
    Harm Reduct J; 2019 Jan; 16(1):4. PubMed ID: 30634986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study.
    Kennedy MC; Hayashi K; Milloy MJ; Wood E; Kerr T
    PLoS Med; 2019 Nov; 16(11):e1002964. PubMed ID: 31770391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study.
    Marshall BD; Milloy MJ; Wood E; Montaner JS; Kerr T
    Lancet; 2011 Apr; 377(9775):1429-37. PubMed ID: 21497898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and implementation of an opioid overdose prevention and response program in Toronto, Ontario.
    Leece PN; Hopkins S; Marshall C; Orkin A; Gassanov MA; Shahin RM
    Can J Public Health; 2013 Apr; 104(3):e200-4. PubMed ID: 23823882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Small communities, large oversight': The impact of recent legislative changes concerning supervised consumption services on small communities in Ontario, Canada.
    Russell C; Imtiaz S; Ali F; Elton-Marshall T; Rehm J
    Int J Drug Policy; 2020 Aug; 82():102822. PubMed ID: 32563756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neighborhood-Level and Spatial Characteristics Associated with Lay Naloxone Reversal Events and Opioid Overdose Deaths.
    Rowe C; Santos GM; Vittinghoff E; Wheeler E; Davidson P; Coffin PO
    J Urban Health; 2016 Feb; 93(1):117-30. PubMed ID: 26800987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using synthetic controls to estimate the population-level effects of Ontario's recently implemented overdose prevention sites and consumption and treatment services.
    Panagiotoglou D; Lim J
    Int J Drug Policy; 2022 Dec; 110():103881. PubMed ID: 36274565
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.